Human Immunodeficiency Virus (HIV) Diagnosis Market Size, Insights Forecast, Growth, Trends 2024-2033

The human immunodeficiency virus (hiv) diagnosis global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.

Human Immunodeficiency Virus (HIV) Diagnosis Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.

Market Size –

The HIV diagnosis market size has grown rapidly in recent years. It will grow from $3.79 billion in 2023 to $4.2 billion in 2024 at a compound annual growth rate (CAGR) of 11%. The growth in the historic period can be attributed to expansion of voluntary counseling and testing, development of HIV antibody tests, emergence of the HIV/AIDS epidemic, and community-led and peer-led initiatives.

The HIV diagnosis market size is expected to see rapid growth in the next few years. It will grow to $6.42 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to public health campaigns and awareness initiatives, focus on equity and inclusivity, routine testing in healthcare settings, community-led and peer-led approaches, and expansion of self-testing. Major trends in the forecast period include advancements in testing technologies, focus on targeted testing strategies, community-based testing and outreach, emphasis on equity and inclusivity, and policy and funding priorities.

Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/human-immunodeficiency-virus-hiv-diagnosis-global-market-report

Scope Of Human Immunodeficiency Virus (HIV) Diagnosis Market

The Business Research Company’s reports encompass a wide range of information, including:

1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.

2. Drivers: Examination of the key factors propelling market growth.

3. Trends: Identification of emerging trends and patterns shaping the market landscape.

4. Key Segments: Breakdown of the market into its primary segments and their respective performance.

5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.

6. Macro Economic Factors: Assessment of broader economic elements impacting the market.

Human Immunodeficiency Virus (HIV) Diagnosis Market Overview

Market Drivers –

The rising blood donation is expected to propel the growth of the HIV diagnosis market going forward. Blood donation refers to the voluntary act of giving blood through phlebotomy, where a needle is inserted into a vein to collect blood. The rise in blood donation combines advancements in medical technology, community engagement, and improved donor recruitment and retention strategies. With more people donating blood, a larger pool of samples is available for HIV testing. This increased availability of blood samples allows for more comprehensive screening for HIV antibodies or antigens, improving the accuracy and reliability of HIV diagnosis. For instance, NHS Blood and Transplant, a UK-based government agency, increased the number of new blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024. Therefore, rising blood donation is driving the growth of the HIV diagnosis market.

Market Trends –

Major companies operating in the HIV diagnosis market are developing chip-based real-time PCR test solutions for HIV to improve accuracy, reduce turnaround time, and enhance accessibility. Chip-based real-time PCR test solutions for HIV are diagnostic tools that utilize microfluidic chips or small integrated circuits to conduct real-time polymerase chain reaction (PCR) tests for detecting HIV. For instance, in August 2022, Molbio Diagnostics, an India-based molecular diagnostics manufacturer, launched the Truenat HIV-1 test, a chip-based real-time PCR test for the quantitative detection and diagnosis of human immunodeficiency virus type 1 (HIV-1) in whole blood and plasma. This test is designed to aid in the monitoring of the HIV-1 viral load in patients with HIV-1 infection. The test is based on Taqman chemistry and features high primer sensitivity and specificity. It requires a minimal sample volume of 6 mcL and includes an intelligent chip with lot-specific data to quantify results. The test consists of a chip re-use lock and a reaction port with contamination- and evaporation-resistant design.

The human immunodeficiency virus (HIV) diagnosis market covered in this report is segmented –

1) By Product: Consumables, Instruments, Software And Services
2) By Mode: Self-Test, Lab-Based
3) By End User: Diagnostic Laboratories, Hospitals, Research Institutions

Get an inside scoop of the human immunodeficiency virus (hiv) diagnosis market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15587&type=smp

Regional Insights –

North America was the largest region in the HIV diagnosis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (HIV) diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Key Companies –

Major companies operating in the human immunodeficiency virus (HIV) diagnosis market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics , Becton Dickinson and Company, Hologic Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc. , OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Biochemicals Ltd., Advanced Molecular Diagnostics, Atila BioSystems Inc., BioAssay Works LLC, Chemtron Biotech Inc.

Table of Contents
1. Executive Summary
2. Human Immunodeficiency Virus (HIV) Diagnosis Market Report Structure
3. Human Immunodeficiency Virus (HIV) Diagnosis Market Trends And Strategies
4. Human Immunodeficiency Virus (HIV) Diagnosis Market – Macro Economic Scenario
5. Human Immunodeficiency Virus (HIV) Diagnosis Market Size And Growth
.
.
.
32. Global Human Immunodeficiency Virus (HIV) Diagnosis Market Competitive Benchmarking
33. Global Human Immunodeficiency Virus (HIV) Diagnosis Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Human Immunodeficiency Virus (HIV) Diagnosis Market
35. Human Immunodeficiency Virus (HIV) Diagnosis Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model